DME Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
DME Capital Management's LKFT Position: Q3 2026 in Review
DME Capital Management held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q3 2026 at 482,746 shares worth $14.3M. The position accounts for 0.4% of the portfolio, ranked #40.
DME Capital Management first reported a position in LKFT in Q1 2024 and has held it in 11 quarters since. The position peaked at $16.7M in Q3 2025. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- DME Capital Management held 482,746 shares of Lakefront Biotherapeutics American Depositary Shares worth $14.3M as of Q3 2026.
- DME Capital Management left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up 0.4% of DME Capital Management's portfolio in Q3 2026, its #40 holding.
- DME Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2024 and has held it in 11 quarters since.
- DME Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $16.7M in Q3 2025.
- 92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on DME Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.